Intellia Therapeutics Inc (FRA:38I)
€ 11.365 -0.31 (-2.66%) Market Cap: 1.17 Bil Enterprise Value: 635.81 Mil PE Ratio: 0 PB Ratio: 1.27 GF Score: 56/100

Q4 2023 Intellia Therapeutics Inc Earnings Call Transcript

Feb 22, 2024 / 01:00PM GMT
Release Date Price: €23.91 (-3.24%)
Operator

Good morning, and welcome to the Intellia Therapeutics Fourth Quarter and Full Year 202320 financial results conference call. My name is Drew, and I will be your conference operator today. (Operator Instructions) I will now turn the conference over to Ian Karp, Senior Vice President of Investor Relations and Corporate Communications at Intellia. Please proceed.

Ian Karp
Intellia Therapeutics Inc - SVP, IR and Corporate Communications

Thank you, operator, and good morning, everyone, and welcome to Intellia Therapeutics Fourth Quarter and Full Year 2023 earnings. Earlier this morning, Intellia issued a press release outlining the company's progress this quarter as well as topics for discussion on today's call. This release can be found on the Investors and Media section of Intellia's website at Intelliatx.com. This call is being broadcast live and a replay will be archived on the Company's website.

At this time, I would like to take a minute to remind listeners that during the call, Intellia management may make certain forward-looking statements and ask

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot